Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story
J Clin Oncol
.
2013 Sep 10;31(26):3291-3.
doi: 10.1200/JCO.2013.50.2617.
Epub 2013 Aug 12.
Authors
Francesco Gelsomino
1
,
Francesco Agustoni
,
Monica Niger
,
Marika Valota
,
Eva R Haspinger
Affiliation
1
Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy.
PMID:
23940223
DOI:
10.1200/JCO.2013.50.2617
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung / drug therapy*
ErbB Receptors / antagonists & inhibitors*
Humans
Lung Neoplasms / drug therapy*
Substances
ErbB Receptors